QNCX

Conviction 80HealthcareScan · Mon, Jul 20, 2026

Bearish engulfing

QNCX$18.62-1.38%

ResistanceSupportVol 14

Vol MA14 48.55K

Apr 20May 6May 26Jun 11Jul 1Jul 20

Quince Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.quincetx.com ↗

Price18.62

Change-1.38%

Gap+2.60%

Rel volume0.40×

Avg volume129.17K

Avg $ vol701.42K

SMA 2012.80

SMA 505.77

SMA 2002.67

Price vs 50+222.97%

Price vs 200+596.39%

MA stackbullish

50/200 cross—

Supertrendup · 14.22

RSI (14)82

MACD hist0.17

MACD cross—

Stoch %K / %D63 / 81

ADX (14)55

+DI / −DI50 / 8

RSI divergenceBearish

MACD divergenceBearish

ATR %+7.90%

ADR %8.42%

52w high19.29

52w low0.0800

From 52w high-3.47%

Above 52w low+23175.00%

New 52w highNo

SqueezeOff

Bollinger width243.31%

%B0.69

Donchian pos89.41%

Donchian high20.72

Donchian low0.8840

AVWAP (52w high)18.94

vs AVWAP high-1.70%

AVWAP (52w low)0.2242

vs AVWAP low+8206.26%

OBV trendDown

Chaikin MF (20)-0.08

Today vs 20d0.40×

Avg vol (14d)48.55K

Avg vol (20d)129.17K

Avg $ vol (20d)701.42K

Market cap303.52M

RS 3m (vs SPY)+1303.02%

RS 6m (vs SPY)+519.58%

RS line new highNo

Trend template8/8

Technical rank98.1

1 week+7.94%

1 month+1962.02%

3 months+1259.12%

6 months+546.53%

1 year+917.49%

YTD+520.67%

P/E-3.61

P/B19.37

P/S—

P/FCF-7.27

EPS-1.68

Div yield—

ROE-535.85%

ROA-315.44%

Debt/Eq0.00

Current2.92

EV/EBITDA-4.93

Gross margin—

Net margin—

Rev growth—

EPS growth-47.78%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value285.36M

Revenue—

Net income35.91M

Gross profit—

Free cash flow-41.78M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out16.3M

Employees38

ListedThu, May 9, 2019

Free float46.73M

Float %83.9%

Short interest112.79K

Days to cover4.8d

Short volume33.0%

Squeeze score24 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$11.80

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank98.1 / 100

Group rank23 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QNCX

All disclosures →

No recent disclosed trades by Congress in QNCX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QNCX

No recent insider (Form 4) filings in QNCX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in QNCX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.